THB Asset Management’s Utah Medical Products UTMD Stock Holding History

THB Asset Management’s Portfolio UTMD Stock Details UTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-8,518	Closed	-$801K	–	163
2020 Q1	$801K	Sell	8,518 -29,134	-77%	-$2.71M	0.25%	97
2019 Q4	$4.06M	Sell	37,652 -6,908	-16%	-$700K	0.75%	50
2019 Q3	$4.27M	Sell	44,560 -9,927	-18%	-$923K	0.79%	55
2019 Q2	$5.21M	Sell	54,487 -3,437	-6%	-$289K	0.83%	50
2019 Q1	$5.11M	Sell	57,924 -609	-1%	-$53.5K	0.74%	58
2018 Q4	$4.86M	Buy	58,533 +511	+0.9%	+$45K	0.72%	58
2018 Q3	$5.46M	Buy	58,022 +13,872	+31%	+$1.33M	0.67%	64
2018 Q2	$4.86M	Buy	44,150 +614	+1%	+$64.1K	0.59%	78
2018 Q1	$4.3M	Buy	43,536 +5	+0%	+$446	0.56%	80
2017 Q4	$3.54M	Buy	+43,531	New	+$3.4M	0.47%	88

Other funds holding UTMD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

THB Asset Management's UTMD Position: Q2 2020 in Review

THB Asset Management sold out of Utah Medical Products (UTMD) in Q2 2020, closing a stake of 8,518 shares — an estimated $801K sold.

THB Asset Management first reported a position in UTMD in Q4 2017 and held it in 10 quarters. The position peaked at $5.46M in Q3 2018. 93 funds tracked by Wall St. Rank hold UTMD as of Q2 2020.

THB Asset Management reported no remaining Utah Medical Products position as of Q2 2020 after selling out during the quarter.
THB Asset Management sold 8,518 Utah Medical Products shares in Q2 2020, an estimated $801K.
THB Asset Management first reported a position in Utah Medical Products in Q4 2017 and held it in 10 quarters.
THB Asset Management's Utah Medical Products position peaked at $5.46M in Q3 2018.
93 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2020.

Based on THB Asset Management's 13F filing for Q2 2020, filed 10 Aug 2020.